Finding Value in a Growth-Stocked Market: A Screen for Undervalued US Mid-Caps

Finding Value in a Growth-Stocked Market: A Screen for Undervalued US Mid-Caps

The current US equity market presents a paradox. Major indices like the S&P 500 and NASDAQ frequently hover near all-time highs, yet this performance is often driven by a concentrated cohort of mega-cap technology and growth stocks. For the discerning investor, this creates a challenging environment: valuations in these popular segments feel stretched, and the fear of buying at a peak is palpable. The relentless narrative around artificial intelligence, cloud computing, and digital transformation, while grounded in real trends, has pushed prices of the perceived winners to levels where future returns may be muted.

In this climate, where does an investor seeking both opportunity and prudence turn?

The answer may lie in a often-overlooked segment of the market: US mid-cap companies. Occupying a unique “sweet spot” between the explosive potential of small-caps and the stability of large-caps, the mid-cap universe is a hunting ground for mispriced assets. It is here, away from the glare of Wall Street’s brightest spotlights, that one can still execute a classic value-investing strategy—even in a market seemingly dominated by growth.

This article is designed for the investor who believes that price matters. We will delve beyond simplistic price-to-earnings ratios and explore a comprehensive, multi-factor screening methodology to identify undervalued US mid-cap stocks. This approach combines quantitative rigor with qualitative assessment, adhering to the principles of Experience, Expertise, Authoritativeness, and Trustworthiness (EEAT). Our goal is not to provide a simple stock tip, but to equip you with a durable framework for finding quality companies trading at a discount to their intrinsic value.

Part 1: Understanding the Mid-Cap Advantage

Before we build our screen, it’s crucial to understand why the mid-cap space is particularly fertile ground for value investors.

Defining the Mid-Cap Universe

In the US, mid-cap companies are typically defined as those with a market capitalization between $2 billion and $10 billion. This range is fluid; some indices and funds may use $1 billion to $15 billion. For our purposes, we’ll focus on the $2B-$10B range, as it captures established, yet still agile, enterprises.

  • Examples for Context: A company like Etsy (ETSY), with a market cap fluctuating around $8-10 billion, is a quintessential mid-cap. It’s a well-known, established platform but is dwarfed by a large-cap like Amazon. A company like Chegg (CHGG), the education technology platform, also resides in this range, as do hundreds of industrial, financial, healthcare, and consumer discretionary firms.

The “Sweet Spot” Thesis: Agility Meets Stability

Mid-caps offer a compelling blend of characteristics that both growth and value investors can appreciate:

  1. Growth Potential: Unlike many large-caps, which face the law of large numbers, mid-caps are often in a phase of accelerating or sustained growth. They have proven business models and are expanding their market share, entering new regions, or launching new product lines. Their growth runway is typically longer than that of a mature large-cap.
  2. Operational Agility: Mid-sized companies are often nimbler than their gargantuan counterparts. They can pivot strategies, adopt new technologies, and capitalize on niche market opportunities without the bureaucratic inertia that can plague massive corporations.
  3. Financial Resilience: Compared to small-caps, mid-caps generally have stronger balance sheets, more diversified revenue streams, and better access to capital markets. This financial footing provides a crucial margin of safety during economic downturns.
  4. Analyst Neglect: While not completely ignored, mid-caps receive significantly less coverage from Wall Street analysts than the Apple or Microsofts of the world. This lower level of scrutiny can lead to pricing inefficiencies—where a company’s true value is not fully reflected in its stock price, creating the very opportunity value investors seek.

Part 2: The Philosophy of Value Investing in a Growth World

The core tenet of value investing, as pioneered by Benjamin Graham and perfected by Warren Buffett, is simple in theory but difficult in practice: buy a dollar’s worth of assets for fifty cents. In today’s market, the definition of “assets” has expanded beyond mere physical plant and inventory to include intangible assets like intellectual property, network effects, and brand value.

The Pitfalls of a P/E-Only Approach

Relying solely on a low Price-to-Earnings (P/E) ratio is a dangerous oversimplification. A stock can be “cheap” for a reason—it might be a company in a terminal decline, a value trap. Our screen must, therefore, look for justifiably undervalued companies—those where the low price is a temporary misperception by the market, not a reflection of a broken business.

The “GARP” Bridge: Growth at a Reasonable Price

For our purposes, we will adopt a GARP (Growth at a Reasonable Price) mindset. We are not seeking deep-value cigar butts (companies selling for less than their net current assets) nor are we chasing hyper-growth at any price. We are seeking quality companies with solid growth prospects that are trading at a reasonable, or even discounted, valuation relative to their future potential. This bridges the gap between pure value and pure growth investing.

Part 3: Building the Screen – A Multi-Factor Methodology

A robust screen uses multiple filters to whittle down the universe of several thousand mid-cap stocks to a manageable list of high-potential candidates. No single metric is a silver bullet; it’s the combination that provides conviction.

We will use a three-pillar approach:

  1. Valuation Pillar: Is the stock statistically cheap?
  2. Quality & Financial Health Pillar: Is the underlying business strong?
  3. Growth & Momentum Pillar: Is there a positive trajectory?

Pillar 1: Valuation Metrics

These metrics help us identify stocks that are priced low relative to their financial fundamentals.

  • EV/EBITDA (Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization): This is often superior to P/E because it is capital-structure neutral. It compares the total value of the company (debt + equity) to its core operating profitability. We will screen for companies with an EV/EBITDA below the median for the mid-cap index (e.g., the S&P MidCap 400), which historically hovers around 10-12. A target of < 10 is a strong starting point.
  • Price-to-Free-Cash-Flow (P/FCF): Cash flow is harder to manipulate than earnings and is the lifeblood of a business. A low P/FCF indicates the market is paying little for each dollar of cash the company generates. We will look for P/FCF < 15 as a sign of undervaluation.
  • Price-to-Book (P/B) Ratio: While less relevant for asset-light tech firms, P/B remains useful for more traditional industries (finance, industrials). It compares the market’s valuation to the company’s accounting value. A P/B < 2 can be a useful filter, but it must be used in context.

Pillar 2: Quality & Financial Health Metrics

This is our defense against value traps. A cheap stock is only a good investment if the company is financially sound.

  • Return on Equity (ROE) or Return on Invested Capital (ROIC): ROE measures how efficiently a company generates profits from shareholders’ equity. ROIC is even better, as it measures returns on all capital invested in the business. We want companies that are good at what they do. A screen for ROIC > 10% helps ensure we are looking at quality businesses.
  • Debt-to-Equity Ratio or Debt-to-EBITDA: Excessive debt is a major risk. We want companies with manageable leverage. A Debt-to-Equity ratio < 1.0 or a Debt-to-EBITDA ratio < 3.0 are strong indicators of financial stability.
  • Current Ratio: A measure of short-term liquidity. A Current Ratio > 1.5 suggests the company can comfortably meet its short-term obligations.

Pillar 3: Growth & Momentum Metrics

A cheap, high-quality company that is stagnating may never be revalued by the market. We need signs of life and a positive trend.

  • Earnings & Revenue Growth: We are looking for sustained, not sporadic, growth. Screening for positive revenue growth over the last 3-5 years and positive EPS growth signals a healthy, expanding business.
  • Revision Momentum: Are analysts revising their earnings estimates upward? A trend of upward revisions can be a powerful leading indicator. Screening for stocks with a positive EPS revision trend over the last 90 days can help identify improving sentiment.
  • Relative Strength (RS): While value investors often shun momentum, buying a stock that is already in a slight uptrend is preferable to catching a falling knife. We can screen for stocks with an RS rating above 60 (on a scale of 1-99), indicating they are outperforming 60% of the market. This avoids the very worst performers.

Putting It All Together: The Composite Screen

Using a professional screening tool (like those on Bloomberg, FactSet, or even advanced retail platforms like Finviz or TradingView), we can combine these criteria:

Initial Universe: All US-listed stocks with Market Cap between $2B and $10B.
Valuation Filters: EV/EBITDA < 10, AND P/FCF < 15.
Quality Filters: ROIC > 10%, AND Debt-to-Equity < 1.0.
Growth/Momentum Filters: 3-Year Revenue Growth > 5%, AND EPS Revision (90 days) > 0%.

This stringent screen will likely produce a list of 20-50 companies from a universe of over 1,000. This is your starting shortlist for deep, qualitative due diligence.

Part 4: From Screen to Due Diligence – The Qualitative Deep Dive

A screen provides candidates; it does not provide answers. The real work begins now. This is where expertise and judgment separate the successful investor from the mere screener.

For each company on your shortlist, you must become a business analyst. Ask the following questions:

  1. What is the Moat? Why is this company difficult to compete against? Does it have a strong brand (a la Yeti (YETI)), patented technology, regulatory licenses, network effects, or cost advantages? A wide moat protects those high returns on capital.
  2. What is the Management Quality? Read the CEO and CFO letters in the annual report (Form 10-K). Are they candid, rational, and shareholder-oriented? Look at management’s track record of capital allocation. Have they been smart acquirers? Do they return capital to shareholders via sensible buybacks and dividends?
  3. What is the Industry Context? Is the company operating in a growing, stable, or declining industry? Is it a cyclical business (e.g., industrials, semiconductors) where the current “cheap” valuation might just be a point in the cycle? Understanding the industry dynamics is crucial to contextualizing the numbers.
  4. Why is it Undervalued? Form a hypothesis for the mispricing. Is it a temporary headwind? A missed earnings quarter that was over-punished? A lack of analyst coverage? A negative news story that doesn’t impact the long-term thesis? If you cannot articulate why the market is wrong, you should not invest.

Part 5: A Hypothetical Case Study – Applying the Framework

Let’s walk through a hypothetical analysis of a fictional company, “Precision Components Inc. (PCI),” which appeared on our screen.

  • The Screen Result: PCI, Market Cap: $4.5B, EV/EBITDA: 8.5, P/FCF: 12, ROIC: 14%, Debt-to-Equity: 0.6, Revenue Growth (3yr avg): 8%, EPS Revisions: +5%.
  • Qualitative Deep Dive:
    • Business Model: PCI manufactures highly engineered, proprietary components for the aerospace and defense industry. Its parts are critical for next-generation aircraft and have long qualification cycles, creating a high barrier to entry.
    • The Moat: Its moat is built on intellectual property (patents) and switching costs. Once a component is certified in an aircraft model, it is extremely costly and time-consuming for the manufacturer to switch suppliers.
    • Management: The CEO is an engineer who founded the company 20 years ago. The 10-K letter is focused on long-term R&D and market share, not quarterly gyrations. The company has a history of judiciously reinvesting cash flow.
    • The Undervaluation Thesis: PCI missed its revenue guidance last quarter due to supply chain delays from a single provider. The stock sold off 25%. Your research indicates the supply chain issue is temporary and has already been resolved by sourcing from a new supplier. The long-term contracts and demand from the aerospace upcycle remain intact. The market overreacted to a short-term, solvable problem.

In this scenario, the quantitative screen identified a statistically cheap, high-quality company, and the qualitative research provided the conviction that the cheapness was temporary and unjustified.

Read more: Energy Transition in the USA: An Equity Analysis of Oil & Gas vs. Renewable Energy Companies

Part 6: Portfolio Construction and Risk Management

Finding a great idea is only half the battle. Managing a portfolio of these ideas is the other.

  • Diversification: Even with rigorous screening, not all ideas will work out. Ensure your mid-cap value holdings are diversified across several sectors (e.g., industrials, financials, healthcare, tech) to avoid idiosyncratic sector risk.
  • Position Sizing: Allocate capital proportionally to your level of conviction. A standard starting position might be 2-3% of a portfolio for a single mid-cap idea. Avoid the temptation to over-concentrate, no matter how compelling the thesis.
  • The Role of Patience: Value investing is an exercise in patience. It may take quarters, or even years, for the market to recognize the value you’ve identified. Your screen is a starting point for a long-term holding, not a short-term trade.
  • Knowing When to Sell: Have a disciplined sell strategy. Sell if: 1) The price reaches your estimate of intrinsic value, 2) The company’s fundamental moat deteriorates, or 3) Your original investment thesis is proven wrong.

Conclusion: The Patient Hunter’s Reward

In a market captivated by the siren song of growth, the disciplined pursuit of value in the mid-cap arena offers a compelling path to potential outperformance. It is a strategy that requires more work—more digging, more patience, and more independence of thought. The easy money in the obvious names has likely already been made.

By employing a systematic, multi-factor screen to identify statistically undervalued companies and then layering on deep qualitative due diligence to assess their quality and the reason for their mispricing, you position yourself not as a speculator, but as a business owner. You are buying stakes in quality, growing enterprises when they are temporarily on sale.

This process, grounded in the timeless principles of value investing and adapted for the modern market, is the essence of finding value in a growth-stocked market. The opportunities are there, hidden in plain sight within the dynamic world of US mid-caps, waiting for the investor with the right toolset and the temperament to find them.

Read more: The US Infrastructure Boom: An Equity Playplay for the Next Decade


Frequently Asked Questions (FAQ)

Q1: What data sources do you recommend for running this screen?

  • For Retail Investors: Platforms like Finviz (Elite version), TradingView (Pro), and YCharts offer powerful screening tools that include most of the metrics discussed. Your brokerage (e.g., Fidelity, Charles Schwab, TD Ameritrade) may also have a robust stock screener.
  • For Professional Investors: BloombergFactSetRefinitiv Eikon are the industry standards, providing deep data and customization.

Q2: How often should I run this screen?
A monthly review is a reasonable cadence. The market is dynamic, and new opportunities arise as prices and company fundamentals change. Running it too frequently may lead to overtrading, while running it too infrequently could cause you to miss compelling new setups.

Q3: This screen seems very strict. What if it returns very few or no results?
This is a feature, not a bug. A screen that returns hundreds of results is not selective enough. If the screen returns very few results, it indicates that the overall market is highly priced and true bargains are scarce. In such environments, patience is key. You can slightly loosen the criteria (e.g., EV/EBITDA < 12 instead of 10) to see what appears, but this will require even more stringent qualitative work.

Q4: Aren’t mid-caps riskier than large-caps?
They carry different risks. Mid-caps are generally more volatile and may be more susceptible to economic downturns than stalwart large-caps like Procter & Gamble. However, their higher growth potential and lower starting valuations can provide a compensating return. The quality filters in our screen (low debt, high ROIC) are specifically designed to mitigate some of this risk by selecting the most financially sound companies within the segment.

Q5: How does this strategy perform during a recession?
Historically, high-quality value stocks with strong balance sheets (exactly what our screen aims to find) have been more resilient during downturns than highly-valued growth stocks. Their low debt means they are less likely to face financial distress, and their valuation provides a margin of safety. However, no strategy is immune to a broad market decline. Mid-caps will likely fall, but the thesis is that they will fall less and recover faster.

Q6: Can I just invest in a mid-cap value ETF instead?
Yes, and for many investors, that is an excellent, low-effort option. ETFs like the iShares S&P Mid-Cap 400 Value ETF (IJJ) or the Vanguard Mid-Cap Value ETF (VOE) provide instant diversification. However, this article’s strategy is for those seeking alpha—the potential to outperform the index. An active, research-intensive approach aims to pick the most undervalued names within the index, hoping they outperform the broader mid-cap value basket.

Q7: What is the single biggest mistake when using this approach?
The biggest mistake is skipping the qualitative deep dive. Falling in love with the numbers on a screen without understanding the business, its competitive position, and the reason for its undervaluation is a recipe for stumbling into a value trap. The screen is the starting line, not the finish line.


Leave a Reply

Your email address will not be published. Required fields are marked *